Audentes Therapeutics: 2Q Earnings Snapshot
SAN FRANCISCO (AP) _ Audentes Therapeutics Inc. (BOLD) on Tuesday reported a loss of $44.8 million in its second quarter.
The San Francisco-based company said it had a loss of $1.01 per share.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share.
Audentes Therapeutics shares have climbed 74% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $37.03, a drop of 2.5% in the last 12 months.